Transferon en el 2020
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Regulatory Pathway for Licensing Biotherapeutics in Mexico. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®). VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 16 mayo de 2019 Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract Transferon®) Ver...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 27 de febrero de 2023 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer. VER...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....